{
  "docId": "019de071-a0aa-74fc-b780-f72cc7f02158",
  "docSlug": "6af314fff9e6eaaf966098f4c73a6229",
  "documentTitle": "Mink Therapeutics | IPO Presentation Deck | 36 slides",
  "authorId": "mink-therapeutics",
  "authorName": "MiNK Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7860465,
  "pageNumber": 5,
  "pageCount": 36,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 1,
  "notes": "The slide uses a list-based summary format to outline the company's core value propositions.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-a0aa-74fc-b780-f72cc7f02158/5",
  "deckHref": "/decks/019de071-a0aa-74fc-b780-f72cc7f02158",
  "deckJsonHref": "/decks/019de071-a0aa-74fc-b780-f72cc7f02158.json",
  "deckAnchorHref": "/decks/019de071-a0aa-74fc-b780-f72cc7f02158#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.25,
        "w": 0.12,
        "x": 0.02,
        "y": 0.45
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d1de4987-b620-47aa-bbc0-04c7997c13b5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.85,
        "x": 0.1,
        "y": 0.25
      },
      "kind": "list",
      "text": "Allogeneic Invariant Natural Killer T (iNKT) Cell Platform Leveraging Both Adaptive and Innate Immune Systems\nMultiple Near Term Validation Milestones and Clinical Readouts for AGENT-797\nWholly-owned or Exclusively Licensed Pipeline Developing Both Native iNKT and Engineered iNKT Programs\nProprietary Manufacturing Process Designed to Facilitate Rapid iNKT Cell Production at Scale\nAbility to Investigate iNKT Combinations with Validated Immuno-oncology Therapies\nExperienced Leadership Team with Decades of Biopharmaceutical Expertise",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2b8a5ab7-c269-4fa0-bac9-c03b4a9da2c0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Pioneering Allogeneic iNKT Cell Therapies for Oncology and Other Immune-Mediated Diseases",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "77e78e58-1dc4-4e5a-9d6c-f13046e046df",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "0fb38224-374e-41de-aa88-8d8de1d772c8",
      "evidence": "list/bullet: Allogeneic Invariant Natural Killer T (iNKT) Cell Platform Leveraging Both Adaptive and Innate Immune Systems",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 5,
      "from": 5,
      "beatId": "5edd5bbb-9ab3-4543-ba7f-3e32aefd902e",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Problem",
      "beatSlug": "sequoia-pitch-problem",
      "evidence": "The document starts by presenting an overview of the problem MiNK Therapeutics aims to solve.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 36,
      "from": 5,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "ff1f25c5-6e00-4a50-9457-841955937c0b",
      "evidence": "The document presents the why, what, and how of MiNK's iNKT cell therapies throughout the deck.",
      "position": 0,
      "objective": "Why MiNK Therapeutics' iNKT cell therapies are needed and how they work",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}